This ensures you have an understanding of where to place, how many and why
Vi c ch hot ng c t bm vo glutathione, sau s mang chng vo mt v phn thi b
Appetite suppression often arrives before weight loss, gastrointestinal effects peak after escalation, and both soften as the dose settles
Lean M, C Le Roux C, Fujioka K, et al
Key Takeaways: GLP-1 vs GIP Both are incretin hormones released by your intestines after eating GLP-1 primarily affects appetite, gastric emptying, and insulin secretion GIP influences insulin secretion, glucagon regulation, and fat metabolism Single GLP-1 agonists (semaglutide) produce 14.9% average weight loss Dual GLP-1/GIP agonists (tirzepatide) produce 22.5% average weight loss The dual action appears to create additive rather than merely overlapping effects Both receptor types play important roles in metabolic regulation Understanding the difference helps explain why tirzepatide shows superior results What Are Incretin Hormones
Deponte M